Drug companies have been presenting trial data at the American Society of Clinical Oncology...


Drug companies have been presenting trial data at the American Society of Clinical Oncology meeting in Chicago. Showing good results are J&J's (JNJ) Zytiga for prostate cancer, Roche's (RHHBY.PK) T-DM1 and Avastin for breast and ovarian tumors respectively, Teva's (TEVA) Treanda for the immune system, and Bristol Myers' (BMY) BMS-936558 for lung, kidney and skin cancer.

From other sites
Comments (2)
  • romilar
    , contributor
    Comments (777) | Send Message
     
    If I could only pick two,J&J and BMY would would be the pair.
    3 Jun 2012, 10:19 AM Reply Like
  • klarsolo
    , contributor
    Comments (705) | Send Message
     
    It's nice to have some good news for a change
    3 Jun 2012, 07:53 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs